CHI Advisors as of June 30, 2021
Portfolio Holdings for CHI Advisors
CHI Advisors holds 18 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repare Therapeutics Ord (RPTX) | 18.4 | $79M | 2.5M | 31.18 | |
| Prometheus Biosciences | 16.3 | $70M | 2.9M | 24.56 | |
| Pliant Therapeutics (PLRX) | 16.0 | $69M | 2.4M | 29.12 | |
| Cullinan Oncology (CGEM) | 13.4 | $58M | 2.2M | 25.75 | |
| Vectivbio Hldg Ord Shs | 7.0 | $30M | 2.6M | 11.66 | |
| Oncorus | 5.6 | $24M | 1.7M | 13.80 | |
| Orchard Therapeutics Ads | 4.2 | $18M | 4.1M | 4.39 | |
| Inozyme Pharma (INZY) | 3.7 | $16M | 927k | 17.04 | |
| Larimar Therapeutics (LRMR) | 3.5 | $15M | 1.5M | 9.82 | |
| Ikena Oncology (IKNA) | 2.7 | $11M | 815k | 14.04 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 2.6 | $11M | 1.4M | 8.15 | |
| Akouos | 2.5 | $11M | 858k | 12.55 | |
| Precision Biosciences Ord | 1.9 | $8.2M | 652k | 12.52 | |
| Keros Therapeutics (KROS) | 1.2 | $4.9M | 116k | 42.47 | |
| Corvus Pharmaceuticals (CRVS) | 0.4 | $1.9M | 719k | 2.67 | |
| G1 Therapeutics | 0.3 | $1.1M | 50k | 21.94 | |
| Ovid Therapeutics (OVID) | 0.2 | $854k | 219k | 3.91 | |
| Kezar Life Sciences | 0.2 | $796k | 147k | 5.43 |
